Stimulatory Effect of Antidepressant Drug Pretreatment on Progression of B16F10 Melanoma in High-Active Male and Female C57BL/6J Mice

Marta Kubera,Beata Grygier,Danuta Wrona,Zofia Rogoz,Adam Roman,Agnieszka Basta-Kaim,Boguslawa Budziszewska,Monika Leskiewicz,Danuta Jantas,Wojciech Nowak,Michael Maes,Wladyslaw Lason
DOI: https://doi.org/10.1016/j.jneuroim.2011.09.006
IF: 3.221
2011-01-01
Journal of Neuroimmunology
Abstract:The effect of a two-week desipramine or fluoxetine (10mg/kg, i.p.) pretreatment on B16F10 melanoma growth in 3–5month old female and male C57BL/6J mice differing in behavioral characteristics (high- vs. low-active) was compared. Antidepressant pretreatment increased metastasis formation, shortened the survival, decreased splenocyte anti-tumor natural killer cell cytotoxicity (in vitro), and the pro-inflammatory cytokine IL-12p40, IFN-γ production while it increased anti-inflammatory cytokine IL-10 production in high-active males (desipramine) or females (fluoxetine). The obtained results emphasize a stimulatory effect of pretreatment with antidepressants on progress of B16F10 melanoma that depends on gender and behavioral characteristics of the animal.
What problem does this paper attempt to address?